Myelodysplastic Syndromes (MDS) is a group of diseases that have a variety of different treatments and outcomes. In this episode, we speak to Dr. Colin Vale of Emory University in Atlanta, GA, about the treatments for MDS, the potential for transforming into acute myeloid leukemia (AML), and new strategies to give patients the quality of care that they deserve.

Mentioned on this episode: 

• 
  
• Myelodysplastic Syndromes (MDS)
  
  
• IMerge Phase 3 Study (Imetelstat)
  
  
• Classification Systems
  
  
• Germline Predisposition Article
  
  
• Patient-Doctor Perspectives: Hereditary Myelodysplastic Syndromes (MDS) | The Bloodline with LLS
  
  
• International Prognostic Scoring System
  
  
• Allogeneic Stem Cell Transplantation
  

Additional LLS Support Resources: 

• 
  
• Information Specialists 
  
  
• Financial support
  
  
• Free telephone/web patient programs 
  
  
• Free booklets 
  
  
• Clinical Trial Support Center
  
  
• Young Adult Resources
  
  
• Caregiver support 
  
  
• Caregiver Workbook
  
  
• Survivorship Workbook
  
  
• Online chats 
  
  
• LLS Community 
  
  
• Support groups 
  
  
• Patti Robinson Kaufmann First Connection Program 
  
  
• Free Nutrition Consultations
  

Support for this episode provided by: Taiho Oncology, Inc.

The post Improving Quality of Care for Myelodysplastic Syndromes (MDS) first appeared on The Bloodline with LLS.